Skip to content
Use caution Drug recall · FDA · Published October 24, 2012

GlaxoSmithKline Recalls Advair HFA Due to Stability Failure

GlaxoSmithKline recalls specific lots of Advair HFA inhalation aerosol because they fail to meet particle size distribution specifications. Check your lot numbers immediately.

🇺🇸 FDA recall #D-064-2013DrugGlaxoSmithKline ›
Take action

Contact the company

Recalling firmGlaxoSmithKline, LLC.1011 North Arendell Ave · Zebulon, NC 27597-1217
✎ GovInfoNow plain-language explainer

GlaxoSmithKline is recalling specific lots of Advair HFA inhalation aerosol because the product fails to meet stability requirements for particle size distribution. This defect means the medication may not deliver the correct dose effectively. The recall affects approximately 310,964 units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/48499-glaxosmithkline-llc-recalls-advair-hfa-fluticasone-propionate-45-mcg-and.

Source Summary by GovInfoNow · govinfonow.com/recall/48499-glaxosmithkline-llc-recalls-advair-hfa-fluticasone-propionate-45-mcg-and · Updated October 13, 2026 · FDA enforcement record: FDA #D-064-2013

Cite this page

“GlaxoSmithKline Recalls Advair HFA Due to Stability Failure.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48499-glaxosmithkline-llc-recalls-advair-hfa-fluticasone-propionate-45-mcg-and. Based on FDA recall #D-064-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-064-2013%22&limit=1).

The FDA announced on Oct. 24, 2012, that GlaxoSmithKline LLC voluntarily recalled Advair HFA Inhalation Aerosol units due to stability failures. The agency said the lots failed to meet particle size distribution specifications.

How to tell if you have it

  • Brand: GlaxoSmithKline
  • Product: Advair HFA Inhalation Aerosol
  • NDC: 0173-0715-20
  • Lot codes: 1ZP2465, 1ZP5224, 1ZP5455, 1ZP6916, 1ZP8042, 1ZP9593, 1ZP9900, 1ZP1134, 1ZP3190, 2ZP6531, 2ZP6924, 2ZP7258, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, 2ZP1331, 2ZP2366
  • Expiration dates: Oct-12, Nov-12, Dec-12, Jan-13, Mar-13, Apr-13, May-13, Jul-13, Sep-13, Oct-13, Nov-13
  • Quantity: 310,964 Aerosol Units

The hazard

According to the FDA, the recalled lots failed to meet particle size distribution specifications. The agency classified this as a Class III recall.

Context

GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since 2012-10-08. Other recent recalls of similar products include Tivicay PD Recall (2024-05-17), GlaxoSmithKline ANORO ELLIPTA inhaler recall (2023-12-12), and GlaxoSmithKline Tivicay Tablets (2022-05-13). Other recent recalls of similar products include Golden State Medical Recalls Prasugrel HCl 10mg Tablets (2026-08-21), Safecor Health Fluphenazine Elixir Recall (2026-08-13), and Ajanta Pharma Fenofibrate Capsules Recall (2026-05-28).

How to tell if you have this one

Check your Advair HFA canister for the NDC 0173-0715-20 and one of the following lot numbers with their corresponding expiration dates: Lot 1ZP2465 (Exp Oct-12), 1ZP5224 (Exp Nov-12), 1ZP5455, 1ZP6916 (Exp Dec-12), 1ZP8042, 1ZP9593 (Exp Jan-13), 1ZP9900 (Exp Mar-13), 1ZP1134 (Exp Apr-13), 1ZP3190, 2ZP6531 (Exp May-13), 2ZP6924, 2ZP7258 (Exp Jul-13), 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782 (Exp Sep-13), 2ZP1331 (Exp Oct-13), or 2ZP2366 (Exp Nov-13).

  • Brand
    GlaxoSmithKline
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico.
  • NDC
    0173-0715-20, 0173-0715-22, 0173-0716-20, 0173-0716-22, 0173-0717-20, 0173-0717-22
Recall numberProduct, codes & lotsQuantity
D-064-2013Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.; Lot #: 1ZP2465, Exp Oct-12, 1ZP5224, Exp. Nov-12, 1ZP5455, 1ZP6916, Exp. Dec-12, 1ZP8042, 1ZP9593, Exp Jan-13, 1ZP9900, Exp. Mar-13, 1ZP1134, Exp. Apr-13, 1ZP3190, 2ZP6531, Exp. May-13, 2ZP6924, 2ZP7258, Exp. Jul-13, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, Exp. Sep-13, 2ZP1331, Exp. Oct-13, 2ZP2366, Exp. Nov-13.310,964 Aerosol Units
D-065-2013Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.; 1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13.18,676 Aerosol Units
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Look at the label on your Advair HFA canister to see if it matches one of the recalled lot numbers listed in the record.

  2. Contact Your Pharmacist or Doctor

    If you have a recalled lot, contact your healthcare provider or pharmacist for instructions on how to return the product and obtain a replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Oct 24, 201212. FDA classified it Class III: Nov 23, 201223. Published in FDA’s Enforcement Report: Dec 5, 201234. FDA terminated the recall: Sep 11, 2014420122014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-064-2013 (October 24, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-064-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA